ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow Reinvestment Rate
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Reinvestment Rate of 2.26x as of March 2026, reinvesting $76.70 Million (capex $5.21 Million plus investments $71.49 Million) from operating cash flow of $33.98 Million. Check ACAD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ACADIA Pharmaceuticals Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for ACADIA Pharmaceuticals Inc across 3 annual periods. Explore ACADIA Pharmaceuticals Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year capital reinvestment analysis for ACADIA Pharmaceuticals Inc. For live market cap and broader valuation context, see ACADIA Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.85x | $203.73 Million | $109.84 Million | $4.69 Million | ▲ +841.8% |
| 2024 | 0.20x | $31.06 Million | $157.72 Million | $523.00K | ▼ -95.4% |
| 2023 | 4.31x | $72.05 Million | $16.70 Million | $40.05 Million | — |